The biotech has launched a strategic review to consider options, including a possible sale, following shareholder pressure.

Tempest Therapeutics is eyeing a strategic partner to continue amezalpat’s development amid ‘unavailable capital markets.’ ...

The UK's MHRA has been redesignated as one of the WHO’s collaborating centres for the standardisation and evaluation of ...

PharmaLogic is set to acquire a majority stake in Agilera Pharma to generate the CDMO focusing on radiopharmaceutical ...

APHA executive director Dr Georges C Benjamin has called for HHS secretary Robert F Kennedy, Jr (RFK Jr) to "resign or be ...

On 7 April, at the 2025 American Academy of Neurology (AAN) meeting, a poster presentation by the Peking Union Medical ...

The Inflation Reduction Act (IRA) is expected to influence the clinical development strategies of pharma companies profoundly ...

US President Donald Trump has stated that the country is set to announce “major tariffs” on pharmaceutical imports very soon.

The Montes Claros site in Brazil is just one of many that Novo Nordisk has poured billions of dollars into as part of efforts ...

US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing ...

Pharma CEOs have told EC President von der Leyen they may shift operations towards the US as trade tensions escalate.